DOI:
10.1055/s-00034916
Nervenheilkunde
Ausgabe 02 ·
Volume 22 ·
2003
DOI: 10.1055/s-008-37482
Original- und Übersichtsarbeiten/Original and Review Articles
60
Fegert, J. M.:
Possibilities and limits of psychopharmacological research in children
66
Hildebrandt, A. G.:
German federal government initiatives for improving the safety of prescription drugs for children and youths
70
Weber, H.-J.:
Strategies for pediatric trials
75
Fegert, J. M.:
Ethical and legal issues in treatment of schizophrenic patients with neuroleptics in childhood and youth
80
Gerlach, M.;
Banaschewski, T.;
Warnke, A.;
Rothenberger, A.:
Parkinson’s disease following methylphenidate administration in childhood?
85
Döpfner, M.;
Banaschewski, T.;
Schmidt, J.;
Uebel, H.;
Schmeck, K.;
Gerber, W. D.;
Günter, M.;
Knölker, U.;
Gehrke, M.;
Häßler, F.;
Möhler, E.;
Brünger, M.;
Ose, C.;
Fischer, R.;
Poustka, F.;
Lehmkuh, G.;
Rothenberger, A.:
Long-acting methylphenidate preparation in children with ADHD – a multicenter study
98
Spitzer, M.:
Developmental cognitive neuroscience
104
Schmidt, D.;
Elger, C. E.:
Clinical benefit of Levetiracetam add-on treatment in 774 patients with chronic, drug-refractory epilepsy
Geist & Gehirn
108
